Teon Therapeutics Appoints Glen Giovannetti as Independent Board Member

Teon Therapeutics Appoints Glen Giovannetti as Independent Board Member
News provided by
Share this article
Share this article
SAN FRANCISCO, Jan. 12, 2021 /PRNewswire/ -- Teon Therapeutics, a private biopharmaceutical company developing a focused portfolio of small molecules that modulate metabolic signaling pathways in the tumor microenvironment, today announced the appointment of Glen Giovannetti, to its board of directors. Glen brings over 36 years of leadership success, industry expertise and board governance credentials following his retirement from EY (Ernst & Young) in December 2020. As EY's former Global Biotechnology and Life Sciences Leader, Glen has deep life sciences knowledge and financial governance, risk and reporting expertise. "We are excited to have Glen joining our board," said Ken Horne, President and Chief Operating Officer of Teon Therapeutics. "His experience as lead partner on numerous IPOs and M&A transactions in the biotech industry will be invaluable for Teon as we navigate future growth opportunities."

Related Keywords

Glen Giovannetti ,Feng Deng ,Ken Horne ,Lou Lange ,Ernst Young ,Lina Yao ,Life Sciences Leader ,Teon Therapeutics Inc ,Global Biotechnology ,Chief Operating Officer ,Founding Managing Director ,Northern Light Ventures ,Teon Therapeutics ,Inc ,ஃபெங் டெங் ,கேன் கொம்பு ,லூ லாங்கே ,எர்னிஸ்ட இளம் ,லினா யாவ் ,வாழ்க்கை அறிவியல் தலைவர் ,உலகளாவிய உயிரி தொழில்நுட்பவியல் ,தலைமை இயங்குகிறது அதிகாரி ,ஸ்தாபகம் நிர்வகித்தல் இயக்குனர் ,வடக்கு ஒளி முயற்சிகள் ,இன்க் ,